Interesting similarities exist between irisin and glucagon-like peptide 1 (GLP-1), the latter of which is used in the treatment of type 2 diabetes as a GLP-1 receptor agonist. The gene discussed is FNDC5; the disease is type 2 diabetes mellitus.